Syndax Pharmaceuticals Ownership & Insider Activity

Syndax Pharmaceuticals Inc

SNDXNASDAQ

$13.40

-0.17-1.25%

마지막 업데이트: Oct 23, 4:51 PM

Syndax Pharmaceuticals Ownership & Insider Activity - Benzinga

Syndax Pharmaceuticals (SNDX) institutional and insider ownership, recent insider transactions and ownership breakdown.

Net Insider Activity by Month

Date	Insider	Title	Type	Shares	Price	Value
Jul 8, 2026	Michael A Metzger	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$15.31	$578K
Jun 11, 2026	AJ Nicholas Botwood	HEAD R&D, CMO	SELL	11.765K	$15.94	$441K
Jun 1, 2026	Keith Goldan	CHIEF FINANCIAL OFFICER	SELL	1.177K	$18.99	$22K
Jun 1, 2026	Michael A Metzger	CHIEF EXECUTIVE OFFICER	SELL	6.847K	$18.99	$130K